USC launches first clinical trial of psilocybin therapy for mental health treatment
By
sheilaro
Summary
USC researchers at the Keck School of Medicine, the Brain and Creativity Institute, and the USC Norris Comprehensive Cancer Center have launched the university's first clinical study of psilocybin-assisted therapy for mental health. The trial will investigate the psychedelic compound found in certain mushrooms for its therapeutic potential, building on growing research into psychedelic-assisted treatments for conditions such as depression, anxiety, and other mental health disorders.
Source
bskyUSC launches first clinical trial of psilocybin therapy for mental health treatmentkeck.usc.eduKey quotes
· 2 pulledResearchers at the Keck School of Medicine of USC, the Brain and Creativity Institute at the USC Dornsife College of Letters, Arts and Sciences, and the USC Norris Comprehensive Cancer Center have launched the University of Southern California's first study of psychedelic therapy.
This clinical trial focuses on psilocybin, a psychedelic chemical found in certain types of mushrooms throughout the world, which has shown promise for...
You might also wanna read
Real-World Study Shows Psilocybin Improves Treatment-Resistant Depression Symptoms
A real-world study of psilocybin therapy for treatment-resistant depression (TRD) in routine clinical practice shows clinically meaningful i
mdsc.pe·1d ago
Psilocybin's Impact on Depression and Anxiety in Cancer Patients: Study Findings
A randomized double-blind trial studied the effects of psilocybin on 51 cancer patients with symptoms of depression and anxiety. Results sho
pmc.ncbi.nlm.nih.gov·11mo ago
Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin
economist.com·4mo ago
Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment ha
Psilocybin's Anti-Aging Effects Revealed in New Emory University Study
A new study suggests that psilocybin, the active ingredient in psychedelic mushrooms, may have anti-aging properties by extending cellular l
Severe Alzheimer's patient shows improved cognition and speech after psilocybin dose
A case report describes a woman with severe Alzheimer's disease who, after receiving a large dose of psilocybin, began initiating conversati
newscientist.com·2h agoComments
Sign in to join the conversation.
No comments yet. Be the first.